---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-079823"
form_type: "8-K"
ticker: "INVA"
cik: "0001080014"
company_name: "Innoviva, Inc."
filed_at: "2023-07-11T23:59:59+00:00"
generated_at: "2026-06-13T09:46:48.996709+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Deborah Birx resigns from Innoviva board to become CEO of majority-owned Armata Pharmaceuticals

## Summary
- Deborah L. Birx resigned from the Board and Audit Committee effective July 10, 2023.
- She accepted the CEO position at Armata Pharmaceuticals, a majority-owned Innoviva subsidiary.
- Resignation was not due to any disagreement with the Company's operations, policies, or controls.
- No other Board changes or disagreements disclosed.

## SEC filing metadata
- accession: 0001104659-23-079823
- form_type: 8-K
- ticker: INVA
- cik: 0001080014
- company_name: Innoviva, Inc.
- filed_at: 2023-07-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1080014/000110465923079823/0001104659-23-079823-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1080014/000110465923079823/tm2320969d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-079823
- JSON: https://secwatch.observer/filing/0001104659-23-079823.json
- Plain text: https://secwatch.observer/filing/0001104659-23-079823.txt

## Key facts
- Executive change
  Deborah L. Birx resigned as member of the Board of Directors and chair of the Audit Committee at Innoviva, Inc..
  - Action: resigned
  - Role: member of the Board of Directors and chair of the Audit Committee
  source text: On July 10, 2023, Deborah L. Birx, a member of the Board of Directors of Innoviva, Inc. (the “Board”) and chair of the Audit Committee, resigned from the Board, including the committees of the Board of which she is a member, effective as of July 10, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1080014/000110465923079823/0001104659-23-079823-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.